1 research outputs found
Safety of Traditional Medicine: An Evolving Pharmacovigilance Practices in Ayurveda, Siddha, Unani and Homeopathy (ASU& H) Drugs
The growing use of Ayurveda, Siddha, Unani, and Homeopathy drugs on the global platform has brought public health concerns regarding their safety to the forefront.Increasing over-the-counter use as well misbranding and misleading advertisements of these medicines, raises significant safety concerns, emphasizing the need for stricter regulations and increased awareness. The transition of traditional medicine from personalized remedies to mass production has enhanced accessibility but also introduced challenges.The Ministry of AYUSH reported 809 misleading advertisement complaints (2015-2018) and two deaths linked to herbal medicine consumption over three years. India has developed a robust pharmacovigilance program of Ayurveda, Siddha, Unani, and Homeopathy drugs (ASU & H), began in 2008.The Ministry of AYUSH established a three-tier system led by All India Institute of Ayurveda.Establishing causality in traditional medicine remains challenging due to complex multi-herb formulations, inconsistent coding standards, dosage variability, and quality control concerns. To improve safety monitoring, India is working toward enhanced reporting mechanisms, trained personnel, and regulatory actions against misleading advertisements, ensuring the responsible use of ASU&H medicines.Strengthening global collaboration with digital technologies i.e. digital reporting systems can enhance real-time ADR detection and improve patient safety
